-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

MYLAN Add to My Watchlist

(NSDQ: MYL)

Detailed Quote

Last Price	17.55 (11.20.09 5:20 PM EST)
Change (%)	+0.12 (+0.69%)
Volume	4,093,232
Open	17.44
Previous Close	17.43
Day's Range	17.63 - 17.31
Bid / Ask	17.55 / 17.56

Intraday

3 Month

6 Month

1 Year

Average Volume	7,337,310	Shares Outstanding	305.58M
52-Week Range	7.09 - 18.10	Market Cap	5.4B
P/E Ratio	109.7	Earnings Per Share	0.16
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
BCR	80.72	+0.00 (+0.00)
HSP	46.88	+0.00 (+0.00)
ABC	24.49	+0.00 (+0.00)
SGIOF	20.30	+0.00 (+0.00)
SSDOF	16.75	+0.00 (+0.00)

Thu, Oct 29, 2009
	BioMarin, Human Genome lead drug stocks higher Drug stocks edged higher in early trading with shares of biotech groups BioMarin Pharmaceutical Inc. and Human Genome Sciences leading the pack. - MarketWatch
	Thursday's biggest gaining and declining stocks Among the shares expected to see active trade in Thursday’s session are those of Aetna, Aflac, Avon, First Solar, LSI, Mylan, Newmont Mining, O’Reilly Automotive, P&G, and Symantec. - MarketWatch
Wed, Oct 28, 2009
	Stocks in focus for Thursday Among the shares expected to see active trade in Thursday’s session are those of Exxon, Procter & Gamble and Colgate-Palmolive. - MarketWatch
Sun, Oct 18, 2009
	Israel stocks ease; Teva sues Mylan over Copaxone Israeli stocks gently lower, with weakness in Teva and Bank Leumi offset by strength in Israel Chemicals and its parent as well as in medical-device innovator Given Imaging. - MarketWatch
Thu, Oct 15, 2009
	Weak Dollar And Low Valuation To Boost J&J (JNJ, TEVA, ELN) A couple of key investment merits should eventually allow J&J?s share price to increase markedly. - Investopedia
More Featured Content

Wed, Nov 18, 2009
	Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association - PR Newswire
Thu, Nov 12, 2009
	Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier - PR Newswire
Tue, Nov 10, 2009
	Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories - PR Newswire
Thu, Nov 05, 2009
	PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited - Business Wire
Thu, Oct 29, 2009
	Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32 - PR Newswire
More Press Releases

10/29/09		Q3 2009 Earnings Archive for MYL
07/30/09		Q2 2009 Earnings Archive for MYL
04/30/09		Q1 2009 Earnings Archive for MYL
02/19/09		Q4 2008 Earnings Archive for MYL
10/30/08		Q3 2008 Earnings Archive for MYL

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs